Radiotherapy in the management of synchronous metastatic lung cancer.

Date publication

août 2023

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Dr MARTIN Etienne

Tous les auteurs :
Khalifa J, Lévy A, Sauvage LM, Thureau S, Darréon J, Le Péchoux C, Lerouge D, Pourel N, Antoni D, Blais E, Martin É, Marguerit A, Giraud P, Riet FG

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37574329

Résumé

Metastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review the role of radiotherapy in the management of synchronous metastatic lung cancers.

Mots clés

Cancer bronchique non à petites cellules, Cancer bronchique à petites cellules, Maladie oligométastatique, Non-small cell lung cancer, Oligometastatic disease, Radiotherapy, Radiothérapie, Small-cell lung cancer, Synchrone, Synchronous

Référence

Cancer Radiother. 2023 08 11;: